Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer

Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer

Ning Xie,1,* Tao Qin,1,* Wei Ren,1 Herui Yao,1,2 Yunfang Yu,1 Huangming Hong1 1Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou, People’s Republic of Chin...

Full description

Bibliographic Details
Main Authors: Xie N, Qin T, Ren W, Yao H, Yu Y, Hong H
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Cancer Management and Research
Subjects:
cdk4/6 inhibitor
hr-positive
her2-negative
advanced breast cancer
Online Access:https://www.dovepress.com/efficacy-and-safety-of-cyclin-dependent-kinases-4-and-6-inhibitors-in--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/efficacy-and-safety-of-cyclin-dependent-kinases-4-and-6-inhibitors-in--peer-reviewed-article-CMAR

Similar Items